- Home
- CLPS vs DARE Comparison
CLPS vs DARE Comparison
Compare CLPS & DARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLPS
- DARE
- Stock Information
- Founded
- CLPS 2005
- DARE 2015
- Country
- CLPS Hong Kong
- DARE United States
- Employees
- CLPS 3325
- DARE N/A
- Industry
- CLPS Computer Software: Prepackaged Software
- DARE Biotechnology: Pharmaceutical Preparations
- Sector
- CLPS Technology
- DARE Health Care
- Exchange
- CLPS Nasdaq
- DARE Nasdaq
- Market Cap
- CLPS 26.0M
- DARE 26.3M
- IPO Year
- CLPS 2018
- DARE N/A
- Fundamental
- Price
- CLPS $1.00
- DARE $2.50
- Analyst Decision
- CLPS
- DARE Strong Buy
- Analyst Count
- CLPS 0
- DARE 3
- Target Price
- CLPS N/A
- DARE $12.50
- AVG Volume (30 Days)
- CLPS 9.8K
- DARE 4.4M
- Earning Date
- CLPS 03-05-2025
- DARE 08-11-2025
- Dividend Yield
- CLPS 13.00%
- DARE N/A
- EPS Growth
- CLPS N/A
- DARE N/A
- EPS
- CLPS N/A
- DARE N/A
- Revenue
- CLPS $153,816,045.00
- DARE $25,909.00
- Revenue This Year
- CLPS N/A
- DARE $74,787.57
- Revenue Next Year
- CLPS N/A
- DARE $141.76
- P/E Ratio
- CLPS N/A
- DARE N/A
- Revenue Growth
- CLPS 5.81
- DARE N/A
- 52 Week Low
- CLPS $0.68
- DARE $2.11
- 52 Week High
- CLPS $1.70
- DARE $9.19
- Technical
- Relative Strength Index (RSI)
- CLPS 57.62
- DARE 44.37
- Support Level
- CLPS $0.94
- DARE $2.11
- Resistance Level
- CLPS $1.03
- DARE $9.19
- Average True Range (ATR)
- CLPS 0.04
- DARE 0.62
- MACD
- CLPS 0.01
- DARE 0.03
- Stochastic Oscillator
- CLPS 82.70
- DARE 5.51
About CLPS CLPS Incorporation
CLPS Inc is a holding company. The company through its subsidiaries provides information technology consulting and solutions institutions in the banking, insurance, and financial sectors, both in China and globally. Its products are Risk Control Platform, Transaction Acquiring Platform, Debt Collection Platform, Virtual Bank Training Platform, Credit Card System, and other related products. The company generates its revenue from IT consulting services, Customized IT solution services, and others. Generating the majority of its revenue from the IT consulting service.
About DARE Dare Bioscience Inc.
Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.